Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist Entity disclosure reporting period:   07/01/2023 - 12/31/2023
Authorizing Officer name John F.X. Heffernan
Title Principal
Business name Park Street Strategies, LLC
Address 121 Mount Vernon Street   
City, state, zip code Boston, MA 02108         
Country US
Phone 617-981-0015 

Client Compensation
NameAmount
Horizon Therapeutics USA, Inc. $36,000.00
Karuna Pharmaceuticals, Inc. $36,000.00
Sage Therapeutics, Inc. $33,000.00
UCB, Inc. $22,500.00
Biotechnology Innovation Organization (BIO) $27,000.00
Massachusetts Biotechnology Council, Inc. $60,000.00
PTC Therapeutics, Inc. $30,000.00
Acadia Pharmaceuticals Inc. $30,000.00
Total salaries received $274,500.00

 
Compensation/Salaries Paid
Lobbyist or Entity nameSalaries
John F.X. Heffernan $93,000.00
Total salaries paid $93,000.00
 
Activities, Bill Numbers and Titles
No activities, bill numbers or bill titles were disclosed for this reporting period.
 
Operating Expenses
DateRecipientType of expenseAmount
12/07/2023 Staples Photocopies, scans $99.88
12/21/2023 Apple Computer equipment, supplies $826.62
12/18/2023 MassBio Professional dues $5,400.00
12/31/2023 Meeting House Office & Retail Internet fees $300.00
07/06/2023 UPS Postage, shipping, delivery $17.22
12/31/2023 Meeting House Office & Retail Rent $6,570.90
12/31/2023 Sean C. Heffernan Office and support staff salaries $2,000.00
12/01/2023 Affiliated News Services LLC Professional subscriptions $2,704.00
12/31/2023 AT&T Wireless Telephone, cell phone, handheld $802.84
12/26/2023 Ward & Lawless LLC, compliance support services Other operating expenses $1,330.00
08/02/2023 Ward & Lawless LLC, compliance support services Other operating expenses $900.00
  Total operating expenses $20,951.46
 
Meals, Travel, and Entertainment Expenses
DateLobbyist nameEvent typePayee/VendorAttendeesAmount
07/26/2023Park Street Strategies, LLC Travel Technology Sq., Cambridge, for parking John F.X. Heffernan $48.00
07/26/2023Park Street Strategies, LLC Travel Pi Alley Garage, Boston, for parking John F.X. Heffernan $43.00
09/14/2023Park Street Strategies, LLC Travel Technology Square, Cambridge, for parking John F.X. Heffernan $48.00
10/11/2023Park Street Strategies, LLC Travel Boston Common Garage, Boston, for parking John F.X. Heffernan $28.00
10/18/2023Park Street Strategies, LLC Travel Technology Square, Cambridge, for parking John F.X. Heffernan $29.00
10/26/2023Park Street Strategies, LLC Meal Capital Coffee House, Boston John F.X. Heffernan;Julie Garner $20.58
10/26/2023Park Street Strategies, LLC Travel Boston Common Garage, Boston, for parking John F.X. Heffernan $28.00
11/02/2023Park Street Strategies, LLC Travel Technology Square, Cambridge, for parking John F.X. Heffernan $29.00
11/14/2023Park Street Strategies, LLC Travel Boston Common Garage, Boston, for parking John F.X. Heffernan $28.00
11/15/2023Park Street Strategies, LLC Travel Boston Common Garage, Boston, for parking John F.X. Heffernan $28.00
12/07/2023Park Street Strategies, LLC Travel Technology Square, Cambridge, for parking John F.X. Heffernan $41.00
12/12/2023Park Street Strategies, LLC Travel Passport Parking, Boston, for parking John F.X. Heffernan $4.00
    Total amount $374.58
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
 
Lobbyist: John F.X. Heffernan
Client: Massachusetts Biotechnology Council, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 593 An Act for trauma informed and social and emotional learning supports and training expansion act Support $0.00 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
House Bill 3770 An Act to improve the Commonwealth's competitiveness, affordability, and equity Neutral $0.00 N/A
Senate Bill 732 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
Senate Bill 2397 An Act to improve the Commonwealth's competitiveness, affordability, and equity Neutral $0.00 N/A
House Bill 445 An Act to expand access to computer science coursework Support $0.00 N/A
House Bill 1131 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Neutral $0.00 N/A
House Bill 2249 An Act relative to the availability of prescription medication during an emergency Neutral $0.00 N/A
Senate Bill 704 An Act prohibiting discrimination against 340b drug discount program participants Neutral $0.00 N/A
Senate Bill 1418 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
House Bill 976 An Act requiring full health insurance coverage for individuals with vitiligo Neutral $0.00 N/A
House Bill 1219 An Act enhancing the market review process Neutral $0.00 N/A
Senate Bill 609 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 801 An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis Oppose $0.00 N/A
Executive Office of the Governor Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing Neutral $0.00 N/A
House Bill 934 An Act to enact the pharmacy benefit manager compensation reform Neutral $0.00 N/A
House Bill 1201 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 3901 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 749 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
Senate Bill 2492 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 978 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 1239 An Act establishing Medicare for all in Massachusetts Oppose $0.00 N/A
Senate Bill 612 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 1181 An Act relative to transparency in the workplace Neutral $0.00 N/A
House Bill 850 An Act concerning the use of animals in product testing Neutral $0.00 N/A
House Bill 1197 An Act to provide rapid whole genome sequencing Neutral $0.00 N/A
House Bill 3900 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 744 An Act establishing medicare for all in Massachusetts Oppose $0.00 N/A
Senate Bill 2400 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1 An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1056 An Act establishing a commission to study maximum allowable costs lists Neutral $0.00 N/A
House Bill 2163 An Act relative to postpartum depression screenings Support $0.00 N/A
Senate Bill 656 An Act to reduce the cost of pharmacy benefits Neutral $0.00 N/A
Senate Bill 1369 An Act to establish a pilot program for specialty pharmacy in urology Neutral $0.00 N/A
House Bill 945 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 1208 An Act establishing a state-wide drug repository program Oppose $0.00 N/A
Senate Bill 256 An Act to create and expand student pathways to success Support $0.00 N/A
Senate Bill 783 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Executive Executive Office of Labor and Workforce Development (EOLWD) Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts. Neutral $0.00 N/A
House Bill 592 An Act to create and expand student pathways to success Support $0.00 N/A
House Bill 1150 An Act to ensure access to generic medication Neutral $0.00 N/A
House Bill 3587 An Act to ensure access to prescription medications Oppose $0.00 N/A
Senate Bill 715 An Act to ensure access to prescription medications Neutral $0.00 N/A
Senate Bill 1862 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
House Bill 953 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1215 An Act relative to pharmacy benefit managers Neutral $0.00 N/A
Senate Bill 277 An Act to expand access to computer science coursework Support $0.00 N/A
Senate Bill 799 An Act to advance health equity Neutral $0.00 N/A
Executive Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services) Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants Neutral $0.00 N/A
House Bill 944 An Act reining in premiums through stronger rate review Neutral $0.00 N/A
House Bill 1206 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Neutral $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 767 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 N/A
Senate Bill 2520 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 444 An Act to expand the use of career and academic plans Support $0.00 N/A
House Bill 1074 An Act relative to cancer patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 2197 An Act to protect Massachusetts public health from PFAS Neutral $0.00 N/A
Senate Bill 689 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
Senate Bill 1375 An Act relative to postpartum depression screening Support $0.00 N/A
House Bill 564 An Act incentivizing the awarding of industry-recognized credentials Support $0.00 N/A
House Bill 1147 An Act ensuring access to specialty medications Support $0.00 N/A
House Bill 3009 An Act creating a workforce skills cabinet supporting pathways to success Support $0.00 N/A
Senate Bill 714 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
Senate Bill 1425 An Act relative to pharmacists as healthcare providers Neutral $0.00 N/A
House Bill 943 An Act to reduce co-pays for people with chronic conditions Neutral $0.00 N/A
House Bill 1205 An Act relative to prescription drug price transparency Oppose $0.00 N/A
House Bill 4040 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 750 An Act relative to primary care for you Neutral $0.00 N/A
Senate Bill 2499 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 1016 An Act to enact pharmacy benefit manager duties Neutral $0.00 N/A
House Bill 1247 An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth Neutral $0.00 N/A
Senate Bill 616 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Neutral $0.00 N/A
Senate Bill 1191 An Act relative to pay range disclosure Neutral $0.00 N/A
House Bill 1055 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
House Bill 1250 An Act to advance health equity Neutral $0.00 N/A
Senate Bill 630 An Act ensuring access to specialty medications Neutral $0.00 N/A
Senate Bill 1356 An Act to protect Massachusetts public health from PFAS Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Biotechnology Innovation Organization (BIO)
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 944 An Act reining in premiums through stronger rate review Neutral $0.00 N/A
House Bill 1206 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Neutral $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 767 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 N/A
Senate Bill 2520 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 850 An Act concerning the use of animals in product testing Neutral $0.00 N/A
House Bill 1197 An Act to provide rapid whole genome sequencing Neutral $0.00 N/A
House Bill 3900 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 744 An Act establishing medicare for all in Massachusetts Oppose $0.00 N/A
Senate Bill 2400 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1056 An Act establishing a commission to study maximum allowable costs lists Neutral $0.00 N/A
House Bill 2163 An Act relative to postpartum depression screenings Support $0.00 N/A
Senate Bill 656 An Act to reduce the cost of pharmacy benefits Neutral $0.00 N/A
Senate Bill 1369 An Act to establish a pilot program for specialty pharmacy in urology Neutral $0.00 N/A
House Bill 953 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1215 An Act relative to pharmacy benefit managers Neutral $0.00 N/A
Senate Bill 277 An Act to expand access to computer science coursework Support $0.00 N/A
Senate Bill 799 An Act to advance health equity Neutral $0.00 N/A
Executive Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services) Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants Neutral $0.00 N/A
House Bill 1 An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1074 An Act relative to cancer patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 2197 An Act to protect Massachusetts public health from PFAS Neutral $0.00 N/A
Senate Bill 689 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
Senate Bill 1375 An Act relative to postpartum depression screening Support $0.00 N/A
House Bill 945 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 1208 An Act establishing a state-wide drug repository program Oppose $0.00 N/A
Senate Bill 256 An Act to create and expand student pathways to success Support $0.00 N/A
Senate Bill 783 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Executive Executive Office of Labor and Workforce Development (EOLWD) Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts. Neutral $0.00 N/A
House Bill 564 An Act incentivizing the awarding of industry-recognized credentials Support $0.00 N/A
House Bill 1150 An Act to ensure access to generic medication Neutral $0.00 N/A
House Bill 3587 An Act to ensure access to prescription medications Oppose $0.00 N/A
Senate Bill 715 An Act to ensure access to prescription medications Neutral $0.00 N/A
Senate Bill 1862 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
House Bill 1016 An Act to enact pharmacy benefit manager duties Neutral $0.00 N/A
House Bill 1247 An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth Neutral $0.00 N/A
Senate Bill 616 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Neutral $0.00 N/A
Senate Bill 1191 An Act relative to pay range disclosure Neutral $0.00 N/A
House Bill 943 An Act to reduce co-pays for people with chronic conditions Neutral $0.00 N/A
House Bill 1205 An Act relative to prescription drug price transparency Oppose $0.00 N/A
House Bill 4040 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 750 An Act relative to primary care for you Neutral $0.00 N/A
Senate Bill 2499 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 1055 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
House Bill 1250 An Act to advance health equity Neutral $0.00 N/A
Senate Bill 630 An Act ensuring access to specialty medications Neutral $0.00 N/A
Senate Bill 1356 An Act to protect Massachusetts public health from PFAS Neutral $0.00 N/A
House Bill 978 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 1239 An Act establishing Medicare for all in Massachusetts Oppose $0.00 N/A
Senate Bill 612 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 1181 An Act relative to transparency in the workplace Neutral $0.00 N/A
House Bill 592 An Act to create and expand student pathways to success Support $0.00 N/A
House Bill 593 An Act for trauma informed and social and emotional learning supports and training expansion act Support $0.00 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
House Bill 3770 An Act to improve the Commonwealth's competitiveness, affordability, and equity Neutral $0.00 N/A
Senate Bill 732 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
Senate Bill 2397 An Act to improve the Commonwealth's competitiveness, affordability, and equity Neutral $0.00 N/A
House Bill 934 An Act to enact the pharmacy benefit manager compensation reform Neutral $0.00 N/A
House Bill 1201 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 3901 An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 749 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
Senate Bill 2492 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 976 An Act requiring full health insurance coverage for individuals with vitiligo Neutral $0.00 N/A
House Bill 1219 An Act enhancing the market review process Neutral $0.00 N/A
Senate Bill 609 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 801 An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis Oppose $0.00 N/A
Executive Office of the Governor Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing Neutral $0.00 N/A
House Bill 444 An Act to expand the use of career and academic plans Support $0.00 N/A
House Bill 1131 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Neutral $0.00 N/A
House Bill 2249 An Act relative to the availability of prescription medication during an emergency Neutral $0.00 N/A
Senate Bill 704 An Act prohibiting discrimination against 340b drug discount program participants Neutral $0.00 N/A
Senate Bill 1418 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
House Bill 445 An Act to expand access to computer science coursework Support $0.00 N/A
House Bill 1147 An Act ensuring access to specialty medications Support $0.00 N/A
House Bill 3009 An Act creating a workforce skills cabinet supporting pathways to success Support $0.00 N/A
Senate Bill 714 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
Senate Bill 1425 An Act relative to pharmacists as healthcare providers Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Acadia Pharmaceuticals Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 612 An Act relative to promoting healthcare access and affordability for patients Neutral $0.00 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
Senate Bill 2520 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
Senate Bill 2499 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Horizon Therapeutics USA, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2499 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
Senate Bill 2520 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
Senate Bill 612 An Act relative to promoting healthcare access and affordability for patients Neutral $0.00 N/A
House Bill 978 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 953 An Act relative to consumer deductibles Support $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Karuna Pharmaceuticals, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2499 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
Senate Bill 631 An Act relative to access to care for serious mental illness Neutral $0.00 N/A
Senate Bill 2520 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
House Bill 984 An Act relative to access to care for serious mental illness Neutral $0.00 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
House Bill 989 An Act for supportive care for serious mental illness Neutral $0.00 N/A
Senate Bill 610 An Act for supportive care for serious mental illness Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: PTC Therapeutics, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
Senate Bill 2520 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
Senate Bill 2499 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
Senate Bill 612 An Act relative to promoting healthcare access and affordability for patients Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Sage Therapeutics, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2520 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
Senate Bill 631 An Act relative to access to care for serious mental illness Neutral $0.00 N/A
Senate Bill 610 An Act for supportive care for serious mental illness Neutral $0.00 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
House Bill 2164 An Act relative to patient assessment and notification prior to prescribing certain medications Support $0.00 N/A
Senate Bill 2499 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
House Bill 984 An Act relative to access to care for serious mental illness Neutral $0.00 N/A
House Bill 989 An Act for supportive care for serious mental illness Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: UCB, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2499 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
House Bill 953 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 2520 An Act relative to pharmaceutical access, costs, and transparency Neutral $0.00 N/A
Senate Bill 612 An Act relative to promoting healthcare access and affordability for patients Neutral $0.00 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $0.00 N/A
House Bill 978 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 2197 An Act to protect Massachusetts public health from PFAS Neutral $0.00 N/A
House Bill 982 An Act relative to non-medical switching Support $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateLobbyist nameRecipient nameOffice soughtAmount
07/11/2023 John F.X. Heffernan Brandy Fluker Oakley State Representative, 12th Suffolk $200.00
07/17/2023 John F.X. Heffernan Kevin G. Honan State Representative, 17th Suffolk $200.00
08/03/2023 John F.X. Heffernan John Lawn State Representative, 10th Middlesex $200.00
09/06/2023 John F.X. Heffernan Marjorie Decker State Representative, 25th Middlesex $100.00
10/02/2023 John F.X. Heffernan Maura Healey Governor, Commonwealth of Massachusetts $200.00
10/04/2023 John F.X. Heffernan Sean Garballey State Representative, 23rd Middlesex $200.00
10/10/2023 John F.X. Heffernan Jon Zlotnik State Senator, Worcester and Hampshire $200.00
10/30/2023 John F.X. Heffernan Karen Spilka State Senator, Middlesex amd Norfolk $200.00
11/14/2023 John F.X. Heffernan Sally Kerans State Representative, 13th Essex $200.00
11/15/2023 John F.X. Heffernan Frank Moran State Representative, 17th Essex $200.00
11/16/2023 John F.X. Heffernan Jenny Armini State Representative, 8th Essex $200.00
12/04/2023 John F.X. Heffernan Andrea Campbell Attorney General, Commonwealth of Massachusetts $200.00
12/11/2023 John F.X. Heffernan Rob Consalvo State Representative, 14th Suffolk $200.00
12/19/2023 John F.X. Heffernan Walter Timilty State Senator, Norfolk, Plymouth and Bristol $200.00
12/19/2023 John F.X. Heffernan Paul Feeney State Senator, Bristol and Norfolk $200.00
12/19/2023 John F.X. Heffernan John Cronin State Senator, Worcester and Middlesex $200.00
12/30/2023 John F.X. Heffernan Julian Cyr State Senator, Cape and Islands $200.00
12/30/2023 John F.X. Heffernan Barry Finegold State Senator, Essex and Middlesex $200.00
   Total contributions $3,500.00
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us

Terms and Conditions     Accessibility Statement